Liven Pharma Limited - LIVEN

Rs 32.68

Change -2.31

On Mar 06

Trades end of day

Last trade on Mar 06, 2026 Day's range Rs 32.11 - 34.99
Change Rs -2.31 52 week range Rs 27.82 - 105.74
Open Rs 34.99 Volume 38,553
Close Rs 32.68 Previous Close Rs 32.68

LIVEN Company Meetings

No Meetings
 

LIVEN Trade Activity

Period High Low Volume
1M 54.15 28.85 5,348,126.00; Avg 267,406.30
3M 56.56 28.85 13,594,810.00; Avg 215,790.63
6M 71.31 28.85 32,431,130.00; Avg 253,368.20
1Y 102.42 28.85 93,139,414.00; Avg 374,053.87
 
 

Latest Annual Financials

Financial Year O/S Shares 0.00m
Net Profit Rs 0.00m Market Cap Rs 0.00m
EPS 0.00 P/E 0.00
Par Value Rs 0.00 Book Value 0.00
Net Worth Rs 0.00m Outstanding Shares 0.00m
Dividend Rs 0.00 ROE 0.00%
Dividend Yield 0.00% Divident Payout 0.00%
Earnings Yield 0.00% Sharia No
 

Price Chart

Yasir Mahmood Securities has partnered with TradingView for its charting solution.
A comprehensive trading platform which offers intuitive analytical tools, stock screener and real time economic calendar data to track key financial events.

 

The company is in the Pharmaceuticals sector.

 

Other Companies in This Sector

Company Current Change Date
Abbot Laboratories Rs 913.66 -2.80% Mar 06, 2026
AGP Limited Rs 191.04 -1.02% Mar 06, 2026
BF Biosciences Limited Rs 138.86 -3.56% Mar 06, 2026
Citi Pharma Limited Rs 77.93 -1.85% Mar 06, 2026
Ferozsons Laboratories Limited Rs 333.29 -4.77% Mar 06, 2026
Glaxosmithkline Rs 325.66 -2.24% Mar 06, 2026
Glaxo Healthcare Pakistan Rs 120.23 -3.20% Jan 30, 2023
Haleon Pakistan Limited Rs 776.84 -0.15% Mar 06, 2026
Highnoon Laboratories Rs 839.51 -4.59% Mar 06, 2026
Hoechst Pakistan Limited Rs 3,971.16 -0.25% Mar 06, 2026
IBL Healthcare Limited Rs 40.46 -5.69% Mar 06, 2026
IBL Healthcare Limited (r) Rs 0.00 0.00% Mar 07, 2026
Liven Pharma Limited Rs 32.68 -6.60% Mar 06, 2026
Liven Pharma Limited (r) Rs 0.00 0.00% Mar 07, 2026
Macter International Limited Rs 281.45 -3.45% Mar 06, 2026
 

Shareholding Pattern

Year Individual Institutions Investment Companies Foreign Investors Government Shareholders Other